COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. More Details
Reasonable growth potential with adequate balance sheet.
Share Price & News
How has COLTENE Holding's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CLTN is not significantly more volatile than the rest of Swiss stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: CLTN's weekly volatility (5%) has been stable over the past year.
7 Day Return
CH Medical Equipment
1 Year Return
CH Medical Equipment
Return vs Industry: CLTN matched the Swiss Medical Equipment industry which returned 4.9% over the past year.
Return vs Market: CLTN exceeded the Swiss Market which returned 0.5% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is COLTENE Holding's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StIs COLTENE Holding AG's (VTX:CLTN) Shareholder Ownership Skewed Towards Insiders?
1 month ago | Simply Wall StDoes COLTENE Holding (VTX:CLTN) Have A Healthy Balance Sheet?
1 month ago | Simply Wall StIs It Time To Consider Buying COLTENE Holding AG (VTX:CLTN)?
Is COLTENE Holding undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CLTN (CHF92) is trading below our estimate of fair value (CHF107.65)
Significantly Below Fair Value: CLTN is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: CLTN's PE Ratio (43.8x) is in line with the CH Medical Equipment industry average.
PE vs Market: CLTN is poor value based on its PE Ratio (43.8x) compared to the Swiss market (23.9x).
Price to Earnings Growth Ratio
PEG Ratio: CLTN is poor value based on its PEG Ratio (1.7x)
Price to Book Ratio
PB vs Industry: CLTN is overvalued based on its PB Ratio (7x) compared to the CH Medical Equipment industry average (6.2x).
How is COLTENE Holding forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CLTN's forecast earnings growth (25.4% per year) is above the savings rate (-0.3%).
Earnings vs Market: CLTN's earnings (25.4% per year) are forecast to grow faster than the Swiss market (12.8% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: CLTN's revenue (3.7% per year) is forecast to grow slower than the Swiss market (4.6% per year).
High Growth Revenue: CLTN's revenue (3.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CLTN's Return on Equity is forecast to be high in 3 years time (26.1%)
How has COLTENE Holding performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CLTN has high quality earnings.
Growing Profit Margin: CLTN's current net profit margins (5.1%) are lower than last year (7.4%).
Past Earnings Growth Analysis
Earnings Trend: CLTN's earnings have grown by 3.7% per year over the past 5 years.
Accelerating Growth: CLTN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CLTN had negative earnings growth (-34.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (-34.1%).
Return on Equity
High ROE: CLTN's Return on Equity (15.8%) is considered low.
How is COLTENE Holding's financial position?
Financial Position Analysis
Short Term Liabilities: CLTN's short term assets (CHF138.0M) exceed its short term liabilities (CHF107.4M).
Long Term Liabilities: CLTN's short term assets (CHF138.0M) exceed its long term liabilities (CHF4.9M).
Debt to Equity History and Analysis
Debt Level: CLTN's debt to equity ratio (100.2%) is considered high.
Reducing Debt: CLTN's debt to equity ratio has increased from 20.3% to 100.2% over the past 5 years.
Debt Coverage: CLTN's debt is well covered by operating cash flow (30%).
Interest Coverage: CLTN earns more interest than it pays, so coverage of interest payments is not a concern.
What is COLTENE Holding current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CLTN's dividend (1.63%) is higher than the bottom 25% of dividend payers in the Swiss market (1.62%).
High Dividend: CLTN's dividend (1.63%) is low compared to the top 25% of dividend payers in the Swiss market (3.81%).
Stability and Growth of Payments
Stable Dividend: CLTN's dividend payments have been volatile in the past 10 years.
Growing Dividend: CLTN's dividend payments have fallen over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (71.4%), CLTN's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CLTN's dividends in 3 years are forecast to be covered by earnings (59.6% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Martin Schaufelberger (56 yo)
Mr. Martin Schaufelberger has been the Chief Executive Officer of COLTENE Holding AG since June 1, 2012. Mr. Schaufelberger commands a long and very successful experience in leading mid-sized, companies op...
CEO Compensation Analysis
Compensation vs Market: Martin's total compensation ($USD942.38K) is about average for companies of similar size in the Swiss market ($USD1.20M).
Compensation vs Earnings: Martin's compensation has been consistent with company performance over the past year.
|Chief Executive Officer||8.58yrs||CHF836.31k||0.20% |
|Chief Financial Officer||7yrs||no data||0.051% |
|Chief Operating Officer||2.17yrs||no data||0.91% |
|Vice President of Product Management & Group Marketing||6yrs||no data||0.026% |
Experienced Management: CLTN's management team is seasoned and experienced (6.5 years average tenure).
|Non-Executive Director||11.75yrs||CHF80.44k||0.092% |
|Independent Chairman of the Board||no data||CHF106.37k||0.24% |
|Independent Non-Executive Director||15yrs||CHF84.45k||0.090% |
|Independent Non-Executive Director||7.75yrs||CHF74.02k||0.022% |
|Independent Non-Executive Director||5yrs||CHF64.00k||0.0068% |
|Independent Non-Executive Director||3.83yrs||CHF74.02k||0.0038% |
|Independent Non-Executive Director||2.33yrs||CHF72.89k||0.00054% |
Experienced Board: CLTN's board of directors are considered experienced (6.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
COLTENE Holding AG's company bio, employee growth, exchange listings and data sources
- Name: COLTENE Holding AG
- Ticker: CLTN
- Exchange: SWX
- Founded: 2005
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: CHF549.752m
- Shares outstanding: 5.98m
- Website: https://www.coltene.com
Number of Employees
- COLTENE Holding AG
- Feldwiesenstrasse 20
- St. Gallen
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CLTN||SWX (SIX Swiss Exchange)||Yes||Registered Shares||CH||CHF||Jun 2006|
|M3Z||DB (Deutsche Boerse AG)||Yes||Registered Shares||DE||EUR||Jun 2006|
|CLHL.F||OTCPK (Pink Sheets LLC)||Yes||Registered Shares||US||USD||Jun 2006|
|0QP7||LSE (London Stock Exchange)||Yes||Registered Shares||GB||CHF||Jun 2006|
COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceani...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/01/26 18:05|
|End of Day Share Price||2021/01/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.